Navigation Links
Cell Therapeutics, Inc. Management to Discuss Today's Announcement,of Interim Pixantrone Study Results

SEATTLE, July 11, 2007 /PRNewswire-FirstCall/ -- On Wednesday, July 11, 2007, at 1:30 p.m. Pacific/4:30 p.m. Eastern/10:30 p.m. Central European Time members of Cell Therapeutics, Inc.'s (CTI) management team will host a conference call to discuss today's announcement of the interim results of its phase II/III RAPID trial comparing CHOP-R to CPOP-R, in which pixantrone is substituted for doxorubicin in standard CHOP-R, in first-line treatment of patients with aggressive non-Hodgkin's lymphoma.

                           Conference Call Numbers

                              Wednesday, July 11

       1:30 p.m. Pacific/4:30 p.m. Eastern/10:30 p.m. Central European

                       1-800-240-7305 (US Participants)

                        1-303-262-2137 (International)


                            Live audio webcast at

                             www.cticseattle.com

                     will be archived for post listening

       approximately two hours after call ends, available for five days


     Call-back numbers for post listening available at 6:30 p.m. Eastern:

                       1-800-405-2236 (US Participants)

                        1-303-590-3000 (International)

                             Passcode: 11093505#


     Media Contact:


     Cell Therapeutics, Inc.

     Dan Eramian

     T: 206.272.4343

     C: 206.854.1200

     Susan Callahan

     T: 206.272.4472

     F: 206.272.4434

     E: 

     www.cticseattle.com/media.htm


     Investors Contact:


     Cell Therapeutics, Inc.

     Leah Grant

     T: 206.282.7100

     F: 206.272.4434

     E: 

     www.cticseattle.com/investors.htm

media@ctiseattle.com




Page: 1 2

Related medicine technology :

1. Protalix BioTherapeutics, Inc. Receives Approval from the FDA to Initiate a Phase III Clinical Trial of prGCD
2. Mersana Therapeutics, Inc. to Present Preclinical Data on XMT-1001 at American Association of Cancer Research Annual Meeting
3. Choosing Lab Quality Management Software
4. Optimizing Quality Control Data Management
5. Geron Corp. Licensee TA Sciences Announces Landmark 7/07/07 Teleconference to Answer Questions About TA-65, Their Telomerase Activator With Proven Age Management Benefits
6. Vakzine Projekt Management Reports Positive Clinical Trial Results With Their Therapeutic Prostate Cancer Vaccine VPM4001
7. Oculus Innovative Sciences Microcyn Technology Presented in Poster at European Wound Management Association Conference
8. Weight Management is Not Enough for Cannabinoid Type 1 (CB1) Receptor Antagonists to Become a Commercial Success
9. Advanced Life Sciences to Host Conference Call to Discuss Data From Cethromycins First of Two Phase 3 Pneumonia Trials
10. Medivation to Host Conference Call to Discuss Top-Line 12-Month Results From Dimebon Alzheimers Disease Study
11. Clinical Trial Results Change Standard of Care for Pancreatic Cancer Patients, Future Therapies Discussed
Post Your Comments:
(Date:8/21/2014)... HAMBURG, Germany , Aug. 21, 2014 /PRNewswire/ ... collaborating with Deutsches Elektronen-Synchrotron ( DESY ), a leading ... to speed up management and storage of massive volumes ... Analytics architecture based on IBM software defined technology ... data at peak performance and help scientists worldwide gain ...
(Date:8/21/2014)... Aug. 21, 2014  ACI Clinical ( www.aciclinical.com ... Data Monitoring Committees. Using this solution, ... over industry standard costs and receive the same ... in committee services. Leveraging a decade ... contracting, charter development, statistical programming and meeting facilitation), ...
(Date:8/21/2014)... Aug. 21, 2014 CVS Caremark Corporation (NYSE: ... Reference Yields and consideration payable in connection with its previously ... 7, 2014 for (1) any and all of its 6.250% ... (2) up to a maximum amount of its 6.125% Senior ... Senior Notes due 2017 (collectively, the "Maximum Tender Offer Notes" ...
Breaking Medicine Technology:DESY and IBM Develop Big Data Architecture for Science 2DESY and IBM Develop Big Data Architecture for Science 3ACI Clinical: Innovation and Savings in Data Safety Monitoring Committees 2CVS Caremark Corporation Announces Early Results of Tender Offers, Pricing, Election of Early Settlement and Increase in the Maximum Tender Offer Amount 2CVS Caremark Corporation Announces Early Results of Tender Offers, Pricing, Election of Early Settlement and Increase in the Maximum Tender Offer Amount 3CVS Caremark Corporation Announces Early Results of Tender Offers, Pricing, Election of Early Settlement and Increase in the Maximum Tender Offer Amount 4CVS Caremark Corporation Announces Early Results of Tender Offers, Pricing, Election of Early Settlement and Increase in the Maximum Tender Offer Amount 5CVS Caremark Corporation Announces Early Results of Tender Offers, Pricing, Election of Early Settlement and Increase in the Maximum Tender Offer Amount 6
... EAST BRUNSWICK, N.J., Nov. 3, 2011 Savient Pharmaceuticals, Inc. ... the three and nine months ended September 30, 2011, which ... KRYSTEXXA® (pegloticase). Savient ended the quarter with $202.7 million in ... the quarter.  For the third quarter of 2011, the Company ...
... LOS ANGELES, Nov. 3, 2011 MedInformatix, a ... industry, announced today it has completed certification with ... certification, the MedInformatixVersion 7.5 prescriber software connected through ... exchange prescription information electronically through the Surescripts secure ...
Cached Medicine Technology:Savient Pharmaceuticals Reports Third Quarter 2011 Financial Results 2Savient Pharmaceuticals Reports Third Quarter 2011 Financial Results 3Savient Pharmaceuticals Reports Third Quarter 2011 Financial Results 4Savient Pharmaceuticals Reports Third Quarter 2011 Financial Results 5Savient Pharmaceuticals Reports Third Quarter 2011 Financial Results 6Savient Pharmaceuticals Reports Third Quarter 2011 Financial Results 7MedInformatix Earns Surescripts® Prescription Routing Certification 2MedInformatix Earns Surescripts® Prescription Routing Certification 3
(Date:8/21/2014)... NC -- Researchers have pinpointed the environmental source of ... Southern California for decades. It literally grows on trees. ... of a 13-year-old girl, who spent the summer gathering ... hardest hit by infections of the fungus named ... Cryptococcus , which encompasses a number of species including ...
(Date:8/21/2014)... 21, 2014 (HealthDay News) -- Being born at a low ... 2 diabetes, a new study suggests. The findings may ... that has a high prevalence of low birth weight, the ... women found that those with a low birth weight were ... those with a normal birth weight. The risk of diabetes ...
(Date:8/21/2014)... A new study published this week in the ... with speech problems from 2001-02 to 2010-11 among U.S. ... disability associated with hearing problems. The data underscore the ... who are experiencing communication disorders, according to the ... broader level, the new study, Changing Trends of ...
(Date:8/21/2014)... Hollywood, FL (PRWEB) August 21, 2014 ... being published today in The Journal of the American ... significantly more invasive cancers and reduces unnecessary recalls. Memorial ... participate in the study. , “This study confirms what ... the invasive, harmful cancers we want to find and, ...
(Date:8/21/2014)... According to a new market report published ... - Home Theatre in-a-box, Home audio systems, Home radios, ... Size, Share, Growth, Trends and Forecast, 2013 - 2019,” ... 2012 and is expected to reach USD 20.68 billion ... 2013 to 2019. Europe was the largest contributor to ...
Breaking Medicine News(10 mins):Health News:Fungus deadly to AIDS patients found to grow on trees 2Health News:Low Birth Weights May Put Black Women at Risk for Diabetes 2Health News:New Pediatrics Study Reveals Dramatic Increase in Speech Problems in Children Over Past Decade 2Health News:New Pediatrics Study Reveals Dramatic Increase in Speech Problems in Children Over Past Decade 3Health News:Dr. Mary Hayes: Study Shows 3D Mammography Finds More Invasive Cancers While Reducing Unnecessary Recalls 2Health News:Home Audio Equipment Market Expected to Reach USD 20.68 Billion in 2019 2Health News:Home Audio Equipment Market Expected to Reach USD 20.68 Billion in 2019 3
... therapy to significantly improve overall survival in patients with ... 20 Bayer HealthCare Pharmaceuticals and Onyx ... that the Ministry of Health, Labour and Welfare (MHLW) ... treatment of patients with unresectable hepatocellular carcinoma (HCC), a ...
... Recondo Technology, a leading provider of revenue cycle ... Harry Gambill and Jeff Fritz have joined the ... Gambill began with TransUnion in 1985 and served ... During his 16-year tenure, TransUnion grew from a ...
... high schoolers take to the stage at the House of Blues ... creative seat belt messagesCLEVELAND, May 20 Local teens had a ... at the House of Blues at noon on Tuesday, May 19, ... It High School Seat Belt Challenge, sponsored by Kohl,s, wrapped ...
... C. Mendell and Lloyd H. Malchow Join Digirad Board ... DRAD ) today announced that it has ... H. Malchow to its Board of Directors, effective immediately. ... board to a total of seven members."Steve and Lloyd ...
... 403(b) market are pushing nonprofit clients to eliminate options for participants by ... with 403(b)connect, now is the time to keep provider and investment choices ... ... 2009 -- The new fully automated 403(b)connect by se2 is ...
... CoSign® digital signatures fully integrate with Adobe LiveCycle® ES, decreasing costs ... , ... San Francisco, CA (PRWEB) May 20, 2009 -- ... the CoSign digital signature (standard electronic signature) solution , and ...
Cached Medicine News:Health News:Nexavar Approved in Japan for the Treatment of Advanced Liver Cancer 2Health News:Nexavar Approved in Japan for the Treatment of Advanced Liver Cancer 3Health News:Nexavar Approved in Japan for the Treatment of Advanced Liver Cancer 4Health News:Nexavar Approved in Japan for the Treatment of Advanced Liver Cancer 5Health News:Nexavar Approved in Japan for the Treatment of Advanced Liver Cancer 6Health News:Recondo Technology Announces Two New Board Members 2Health News:Rainbow Babies & Children's Hospital's Use It or Lose It High School Seat Belt Challenge Brings Out the Creativity in Cuyahoga County Teens 2Health News:Rainbow Babies & Children's Hospital's Use It or Lose It High School Seat Belt Challenge Brings Out the Creativity in Cuyahoga County Teens 3Health News:Digirad Names Two Veteran Healthcare Executives to Board 2Health News:Digirad Names Two Veteran Healthcare Executives to Board 3Health News:Digirad Names Two Veteran Healthcare Executives to Board 4Health News:403(b) Administration Now Turn-Key with New 'Single Solution/Multi-Provider' Web Hosted Platform - 403(b)connect 2Health News:403(b) Administration Now Turn-Key with New 'Single Solution/Multi-Provider' Web Hosted Platform - 403(b)connect 3Health News:SAFE-BioPharma Webinar Featuring ARX's Digital Signature Solution and Adobe LiveCycle Combined Solution 2Health News:SAFE-BioPharma Webinar Featuring ARX's Digital Signature Solution and Adobe LiveCycle Combined Solution 3
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: